Merck & Co. (NYSE:MRK) has signed two licensing agreements for investigational HIV drug candidates and also unveiled plans for a study to investigate an internally developed HIV drug candidate. The drug company signed a deal with Chimerix Inc …
Hebei Xingang Pharmaceutical Co., Ltd.
Professional manufacturer of Rifampicin and Rifamycin Derivatives
Merck & Co. (NYSE:MRK) has signed two licensing agreements for investigational HIV drug candidates and also unveiled plans for a study to investigate an internally developed HIV drug candidate. The drug company signed a deal with Chimerix Inc …